The recombinant therapeutic antibodies and proteins industry is undergoing rapid transformation driven by biotechnological innovations and expanding healthcare needs. As demand surges for targeted therapies in oncology, autoimmune diseases, and rare disorders, the competitive landscape evolves with increased focus on optimized production processes and personalized medicine. This repor... https://www.coherentmarketinsights.com/market-insight/recombinant-therapeutic-antibodies-and-proteins-market-1981